ARCHIVES

R.S.K. Young Quits As FDA Oncology Group Leader

This article is from The Cancer Letter archive.

Vol. 06 No. 28 | July 11, 1980

Download PDF Visit The Full Archive

Related Articles

SWOG, NCI Canada halt two large trials of Iressa for non-small cell lung cancer.

April 22, 2005

In Brief: BMS Oncology Names New VP, Marketing; Hortobagyi Wins Freyer Medal; Prerez Honored

October 24, 1997

Text of PDQ Statement on Breast Screening

September 17, 1993

New NCI Director Plans Greater Support For Translational Research, Collaboration.

March 1, 2002

Joe Gray Moves To OHSU Knight Cancer Institute

January 21, 2011

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

January 25, 2013